We recently developed a high throughput T cell receptor β chain (TCRβ) sequencing-based approach to identifying and tracking donor-reactive T cells. To address the role of clonal deletion in liver allograft tolerance, we applied this method in samples from a recent randomized study, ITN030ST, in which immunosuppression withdrawal was attempted within 2 years of liver transplantation. We identified donor-reactive T cell clones via TCRβ sequencing following a pre-transplant mixed lymphocyte reaction and tracked these clones in the circulation following transplantation in 3 tolerant and 5 non-tolerant subjects. All subjects showed a downward trend and significant reductions in donor-reactive TCRβ sequences were detected post-transplant in 6 of 8 subjects, including 2 tolerant and 4 non-tolerant recipients. Reductions in donor-reactive TCRβ sequences were greater than those of all other TCRβ sequences, including 3rd party-reactive sequences, in all 8 subjects, demonstrating an impact of the liver allograft after accounting for repertoire turnover. Although limited by patient number and heterogeneity, our results suggest that partial deletion of donor-reactive T cell clones may be a consequence of liver transplantation and does not correlate with success or failure of early immunosuppression withdrawal. These observations underscore the organ- and/or protocol-specific nature of tolerance mechanisms in humans.
Keywords: T cell biology; basic (laboratory) research/science; immunobiology; liver transplantation/hepatology; monitoring: immune; tolerance.
© 2019 The American Society of Transplantation and the American Society of Transplant Surgeons.
Conflict of interest statement
The authors of this manuscript have conflicts of interest to disclose as described by the
Tracking donor-reactive T cells: Evidence for clonal deletion in tolerant kidney transplant patients.Sci Transl Med. 2015 Jan 28;7(272):272ra10. doi: 10.1126/scitranslmed.3010760. Sci Transl Med. 2015. PMID: 25632034 Free PMC article.
Early expansion of donor-specific Tregs in tolerant kidney transplant recipients.JCI Insight. 2018 Nov 15;3(22):e124086. doi: 10.1172/jci.insight.124086. JCI Insight. 2018. PMID: 30429370 Free PMC article.
Clinical, immunological, and pathological aspects of operational tolerance after pediatric living-donor liver transplantation.Transpl Immunol. 2007 Feb;17(2):94-7. doi: 10.1016/j.trim.2006.10.004. Epub 2006 Nov 10. Transpl Immunol. 2007. PMID: 17306739
Fingerprints of transplant tolerance suggest opportunities for immunosuppression minimization.Clin Biochem. 2016 Mar;49(4-5):404-10. doi: 10.1016/j.clinbiochem.2016.01.007. Epub 2016 Jan 13. Clin Biochem. 2016. PMID: 26794635 Review.
Cellular basis of long-term organ transplant acceptance: pivotal role of intrathymic clonal deletion and thymic dependence of bone marrow microchimerism-associated tolerance.Am J Kidney Dis. 1998 Feb;31(2):197-212. doi: 10.1053/ajkd.1998.v31.pm9469488. Am J Kidney Dis. 1998. PMID: 9469488 Review.
- S10 RR027050/RR/NCRR NIH HHS/United States
- UM1 AI109565/AI/NIAID NIH HHS/United States
- The Transplant Forum/International
- R21 TR002279/TR/NCATS NIH HHS/United States
- S10 OD020056/OD/NIH HHS/United States